[Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
Vermeulen
M
M
Academisch Medisch Centrum, afd. Neurologie, Amsterdam.
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy*; D002648:Child; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology / Q000627:therapeutic use*; D007378:Interleukins / Q000378:metabolism; D009080:Mucocutaneous Lymph Node Syndrome / Q000628:therapy; D011129:Polyradiculoneuropathy / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy; D011961:Receptors, Fc / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D016756:Immunoglobulins, Intravenous; D007378:Interleukins; D011961:Receptors, Fc